Thermo Fisher Scientific (NYSE:TMO)‘s stock had its “neutral” rating reiterated by Zacks in a note issued to investors on Monday, AmericanBankingNews.com reports. They currently have a $103.00 price target on the stock. Zacks‘ price objective would indicate a potential upside of 5.31% from the stock’s previous close.
Zacks‘ analyst wrote, “Thermo Fisher posted a better-than-expected third quarter 2013 results with adjusted EPS of $1.28 and revenues of $3.19 billion, both ahead of the Zacks Consensus Estimate of $1.30 and $3.18 billion. The results also sailed past the year-ago numbers. The company is carrying out all basic procedures to take over Life Technologies which is expected to complete in early 2014. The proposed buyout of Life Technologies is expected to complement Thermo Fisher’s portfolio of analytical technologies and specialty diagnostics. Besides, in a challenging market environment, a 2% organic growth is encouraging. However, economic uncertainties and currency headwind continue to act as major dampeners. We are Neutral’ on the stock.”
Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group raised their price target on shares of Thermo Fisher Scientific from $102.00 to $110.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. Separately, analysts at Cantor Fitzgerald raised their price target on shares of Thermo Fisher Scientific from $100.00 to $112.00 in a research note to investors on Thursday. Finally, analysts at Goldman Sachs Group Inc. raised their price target on shares of Thermo Fisher Scientific from $89.00 to $94.00 in a research note to investors on Friday, September 27th. They now have a “neutral” rating on the stock. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $94.50.
Shares of Thermo Fisher Scientific (NYSE:TMO) traded up 0.02% on Monday, hitting $97.83. The stock had a trading volume of 395,935 shares. Thermo Fisher Scientific has a one year low of $57.21 and a one year high of $92.72. The stock’s 50-day moving average is $90.87 and its 200-day moving average is $84.58. The company has a market cap of $35.336 billion and a P/E ratio of 27.22.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $1.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.28 by $0.02. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.18 billion. During the same quarter last year, the company posted $1.19 earnings per share. Thermo Fisher Scientific’s revenue was up 3.4% compared to the same quarter last year. Analysts expect that Thermo Fisher Scientific will post $5.36 EPS for the current fiscal year.
Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.